Teza Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,589
| Closed | -$62.9K | – | 570 |
|
|
2024
Q4 | $62.9K | Sell |
11,589
-2,180
| -16% | -$11.8K | 0.01% | 464 |
|
|
2024
Q3 | $99.4K | Buy |
13,769
+1,592
| +13% | +$11.5K | 0.01% | 571 |
|
|
2024
Q2 | $132K | Buy |
+12,177
| New | +$132K | 0.02% | 544 |
|
|
2021
Q3 | – | Sell |
-11,562
| Closed | -$657K | – | 560 |
|
|
2021
Q2 | $657K | Buy |
11,562
+6,400
| +124% | +$364K | 0.11% | 253 |
|
|
2021
Q1 | $386K | Buy |
+5,162
| New | +$386K | 0.08% | 327 |
|
|
2020
Q4 | – | Sell |
-5,254
| Closed | -$321K | – | 418 |
|
|
2020
Q3 | $321K | Sell |
5,254
-10,258
| -66% | -$627K | 0.19% | 196 |
|
|
2020
Q2 | $645K | Buy |
+15,512
| New | +$645K | 0.14% | 224 |
|